September 26, 2020

The Niche

Knoepfler lab stem cell blog

Sherley v Sebelius

4 min read

We kind of take for granted these days that embryonic stem cell research can proceed without any restrictions, at least at the federal level. However, in the early days of blogging here on The Niche the big debate and battle were over federal funding of embryonic stem cell research. Things got very complicated and for a time the funding was illegal. We should learn from this science history because things could easily go back to that restrictive atmosphere again. Science is not in a …Read More

3 min read

Every year I do predictions for the stem cell field for the coming year. You can see my full post on my predictions for this year here. Stay tuned soon for my predictions for 2014. How’d I do for 2013 with my predications? Each prediction for this year that I made last year is bolded and my assessment now of how I did for each is in green or red. I did reasonably well for 2013. Sometimes predictions get mixed in with what hopes or …Read More

1 min read

Today the Supreme Court agreed to review three cases, none of which were Sherley v Sebelius. What a great day! For those curious, Certiorari Granted (subheading on Supreme Court announcement) means the Court has granted review of these cases. This is wonderful news for patients, the stem cell field, and probably biotech Advanced Cell Technology (ACT; symbol ACTC). It’s stock was up Friday sharply and is already zooming again today. As much as adult stem cells and iPS cells are great tools for regenerative …Read More

1 min read

The buzz topic in the stem cell field right now is whether the U.S. Supreme Court (SCOTUS) will take up the Sherley v Sebelius (S v S) case over the legality of federal funding of embryonic stem cell research in the U.S. The SCOTUS decision as to whether to hear the S v S should come tomorrow (Monday). I’ve predicted that the SCOTUS will take a pass on the case. The reality is that it could go either way even if I’m hopeful it’ll …Read More